Interventions for valvular disease First-in-Human Evaluation of Balloon Expandable Transcatheter Heart Valve in the Treatment of Severe Symptomatic Native Aortic Stenosis: The MyVal-1 Study Sharma SK, Rao RS, Chandra P, Goel PK, Bharadwaj P, Joseph G, Mahajan A, Mehrotra S, Sengottovelu G, Kumar VA, Manjunath C, Abhaichand RK, Seth A, Jose J, Sethi R October 1, 2019 | 10.4244/EIJ-D-19-00413
New issue Antiplatelet strategies for complex PCI, are all DES equal at 10-year follow-up? cost-effectiveness of TAVR…find all the answers in the new issue (Intravascular lithotripsy (3.5 mm Shockwave; left), followed by balloon dilatation (4.0 mm NC; right)) December 6, 2019
JAA This week's JAA's: EXTREME Study, Stent Optimization, Trifurcation disease and more December 3, 2019
Trials Book New update! Discover 17 new trials (The Trials book is supported by Biotronik) October 29, 2019
Editorial 2019 – A leap year for valvular heart disease (Course directors PCR London Valves 2019) November 15, 2019